Detrimental effects of standard medical therapy in congenital diaphragmatic hernia

David W. Kays, Max Langham, Daniel J. Ledbetter, James L. Talbert

Research output: Contribution to journalArticle

158 Citations (Scopus)

Abstract

Objective: To evaluate the impact of a nonstandard ventilation strategy on survival in congenital diaphragmatic hernia (CDH). Background: Despite recent advances, including nitric oxide, CDH remains an unsolved problem with a mortality rate of 35% to 50%. Hyperventilation and alkalization remain common therapies. Methods: In 1992, the authors prospectively abandoned hyperventilation and alkalization. Patients are lightly sedated and ventilated with the lowest pressure providing adequate chest movement, and the rate is set to patient comfort. Nitric oxide and extracorporeal membrane oxygenation (ECMO) are reserved for life-threatening instability. Surgical repair is delayed 1 to 5 days. Sixty consecutive patients are compared with 29 previous patients treated with hyperventilation and alkalization, 13 before and 16 after the availability of ECMO. Results: Overall, 47 of 60 patients (78%) in study era 3 survived compared with 2 of 13 (15%) in the hyperventilation era and 7 of 16 (44%) in the hyperventilation/ECMO era (p < 0.0001). The disease severity and the incidence of associated anomalies did not differ between groups. To compare management strategies, patients who had treatment withheld because of lethal associated conditions were then removed from analysis. Peak inspiratory pressure and arterial pH were lower (p < 0.0001) and PaCO2 was higher (p < 0.05) in era 3 than in the previous eras. The rate of pneumothorax (1.9%) decreased (p < 0.0001). In era 3, survival was 47 of 53 (89%) treated patients, and 23 of 25 inborn patients with isolated CDH survived (92%). Conclusions: Nonstandard ventilatory support of patients with CDH has led to significantly improved survival rates. This study sets a survival benchmark and strongly suggests the negative effects of hyperventilation and alkalization.

Original languageEnglish (US)
Pages (from-to)340-351
Number of pages12
JournalAnnals of surgery
Volume230
Issue number3
DOIs
StatePublished - Sep 1 1999

Fingerprint

Hyperventilation
Extracorporeal Membrane Oxygenation
Therapeutics
Survival
Nitric Oxide
Benchmarking
Congenital Diaphragmatic Hernias
Pneumothorax
Ventilation
Arterial Pressure
Thorax
Survival Rate
Pressure
Mortality
Incidence

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Detrimental effects of standard medical therapy in congenital diaphragmatic hernia. / Kays, David W.; Langham, Max; Ledbetter, Daniel J.; Talbert, James L.

In: Annals of surgery, Vol. 230, No. 3, 01.09.1999, p. 340-351.

Research output: Contribution to journalArticle

Kays, David W. ; Langham, Max ; Ledbetter, Daniel J. ; Talbert, James L. / Detrimental effects of standard medical therapy in congenital diaphragmatic hernia. In: Annals of surgery. 1999 ; Vol. 230, No. 3. pp. 340-351.
@article{c253b1031dfe425d9c700ea592bce545,
title = "Detrimental effects of standard medical therapy in congenital diaphragmatic hernia",
abstract = "Objective: To evaluate the impact of a nonstandard ventilation strategy on survival in congenital diaphragmatic hernia (CDH). Background: Despite recent advances, including nitric oxide, CDH remains an unsolved problem with a mortality rate of 35{\%} to 50{\%}. Hyperventilation and alkalization remain common therapies. Methods: In 1992, the authors prospectively abandoned hyperventilation and alkalization. Patients are lightly sedated and ventilated with the lowest pressure providing adequate chest movement, and the rate is set to patient comfort. Nitric oxide and extracorporeal membrane oxygenation (ECMO) are reserved for life-threatening instability. Surgical repair is delayed 1 to 5 days. Sixty consecutive patients are compared with 29 previous patients treated with hyperventilation and alkalization, 13 before and 16 after the availability of ECMO. Results: Overall, 47 of 60 patients (78{\%}) in study era 3 survived compared with 2 of 13 (15{\%}) in the hyperventilation era and 7 of 16 (44{\%}) in the hyperventilation/ECMO era (p < 0.0001). The disease severity and the incidence of associated anomalies did not differ between groups. To compare management strategies, patients who had treatment withheld because of lethal associated conditions were then removed from analysis. Peak inspiratory pressure and arterial pH were lower (p < 0.0001) and PaCO2 was higher (p < 0.05) in era 3 than in the previous eras. The rate of pneumothorax (1.9{\%}) decreased (p < 0.0001). In era 3, survival was 47 of 53 (89{\%}) treated patients, and 23 of 25 inborn patients with isolated CDH survived (92{\%}). Conclusions: Nonstandard ventilatory support of patients with CDH has led to significantly improved survival rates. This study sets a survival benchmark and strongly suggests the negative effects of hyperventilation and alkalization.",
author = "Kays, {David W.} and Max Langham and Ledbetter, {Daniel J.} and Talbert, {James L.}",
year = "1999",
month = "9",
day = "1",
doi = "10.1097/00000658-199909000-00007",
language = "English (US)",
volume = "230",
pages = "340--351",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Detrimental effects of standard medical therapy in congenital diaphragmatic hernia

AU - Kays, David W.

AU - Langham, Max

AU - Ledbetter, Daniel J.

AU - Talbert, James L.

PY - 1999/9/1

Y1 - 1999/9/1

N2 - Objective: To evaluate the impact of a nonstandard ventilation strategy on survival in congenital diaphragmatic hernia (CDH). Background: Despite recent advances, including nitric oxide, CDH remains an unsolved problem with a mortality rate of 35% to 50%. Hyperventilation and alkalization remain common therapies. Methods: In 1992, the authors prospectively abandoned hyperventilation and alkalization. Patients are lightly sedated and ventilated with the lowest pressure providing adequate chest movement, and the rate is set to patient comfort. Nitric oxide and extracorporeal membrane oxygenation (ECMO) are reserved for life-threatening instability. Surgical repair is delayed 1 to 5 days. Sixty consecutive patients are compared with 29 previous patients treated with hyperventilation and alkalization, 13 before and 16 after the availability of ECMO. Results: Overall, 47 of 60 patients (78%) in study era 3 survived compared with 2 of 13 (15%) in the hyperventilation era and 7 of 16 (44%) in the hyperventilation/ECMO era (p < 0.0001). The disease severity and the incidence of associated anomalies did not differ between groups. To compare management strategies, patients who had treatment withheld because of lethal associated conditions were then removed from analysis. Peak inspiratory pressure and arterial pH were lower (p < 0.0001) and PaCO2 was higher (p < 0.05) in era 3 than in the previous eras. The rate of pneumothorax (1.9%) decreased (p < 0.0001). In era 3, survival was 47 of 53 (89%) treated patients, and 23 of 25 inborn patients with isolated CDH survived (92%). Conclusions: Nonstandard ventilatory support of patients with CDH has led to significantly improved survival rates. This study sets a survival benchmark and strongly suggests the negative effects of hyperventilation and alkalization.

AB - Objective: To evaluate the impact of a nonstandard ventilation strategy on survival in congenital diaphragmatic hernia (CDH). Background: Despite recent advances, including nitric oxide, CDH remains an unsolved problem with a mortality rate of 35% to 50%. Hyperventilation and alkalization remain common therapies. Methods: In 1992, the authors prospectively abandoned hyperventilation and alkalization. Patients are lightly sedated and ventilated with the lowest pressure providing adequate chest movement, and the rate is set to patient comfort. Nitric oxide and extracorporeal membrane oxygenation (ECMO) are reserved for life-threatening instability. Surgical repair is delayed 1 to 5 days. Sixty consecutive patients are compared with 29 previous patients treated with hyperventilation and alkalization, 13 before and 16 after the availability of ECMO. Results: Overall, 47 of 60 patients (78%) in study era 3 survived compared with 2 of 13 (15%) in the hyperventilation era and 7 of 16 (44%) in the hyperventilation/ECMO era (p < 0.0001). The disease severity and the incidence of associated anomalies did not differ between groups. To compare management strategies, patients who had treatment withheld because of lethal associated conditions were then removed from analysis. Peak inspiratory pressure and arterial pH were lower (p < 0.0001) and PaCO2 was higher (p < 0.05) in era 3 than in the previous eras. The rate of pneumothorax (1.9%) decreased (p < 0.0001). In era 3, survival was 47 of 53 (89%) treated patients, and 23 of 25 inborn patients with isolated CDH survived (92%). Conclusions: Nonstandard ventilatory support of patients with CDH has led to significantly improved survival rates. This study sets a survival benchmark and strongly suggests the negative effects of hyperventilation and alkalization.

UR - http://www.scopus.com/inward/record.url?scp=0033511301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033511301&partnerID=8YFLogxK

U2 - 10.1097/00000658-199909000-00007

DO - 10.1097/00000658-199909000-00007

M3 - Article

VL - 230

SP - 340

EP - 351

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 3

ER -